| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,339,000 | 2,057,000 | 2,230,000 | 2,297,000 | | Cost of Revenue | 1,305,000 | 1,164,000 | 1,192,000 | 1,250,000 | | | Gross Profit | 1,034,000 | 893,000 | 1,038,000 | 1,047,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 391,000 | 382,000 | 450,000 | 440,000 | | Non Recurring |
-
|
-
| 65,000 |
-
| | Others | 6,000 | 5,000 | 6,000 | 5,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 637,000 | 506,000 | 517,000 | 602,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 | 362,000 | 37,000 | 40,000 | | Earnings Before Interest And Taxes | 648,000 | 868,000 | 554,000 | 642,000 | | Interest Expense | 68,000 | 72,000 | 81,000 | 81,000 | | Income Before Tax | 580,000 | 796,000 | 473,000 | 561,000 | | Income Tax Expense | 216,000 | 291,000 | 176,000 | 203,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 364,000 | 505,000 | 297,000 | 358,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 364,000 | 505,000 | 297,000 | 358,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $364,000 | $505,000 | $297,000 | $358,000 |
|
5.11% Nasdaq 0.00%
Income Statement
